Therefore, we assumed that cholecalciferol supplementation in patients with Crohn’s disease has the potential to restore the disabled VD pathway involved in suppressing CCL20 in Crohn’s disease by reestablishing an appropriate level of VD receptor expression. This evidence concerns the gene CCL20 and Crohn disease.